Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification
By Farah Tokmic, PhD; Mirsad Hadzikadic, PhD; James R. Cook, [...]
Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials
by David V. Sheehan, MD, MBA; Maria Gasior, MD, PhD; [...]
Neuroscience is the Next Oncology
by Michael D. Ehlers, MD, PhD Dr. Ehlers is with [...]
Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder
by Steven D. Targum, MD; Christopher Murphy, PhD; Jibran Khan, [...]
Lower-extremity Dynamometry as a Novel Outcome Measure in a Double-blind, Placebo-controlled, Feasibility Trial of Intravenous Immunoglobulin (IVIG) for HIV-associated Myelopathy
by Jessica Robinson-Papp, MD, MS; Mary Catherine George, MM, PhD; [...]
The 30th Anniversary of PANSS Special Edition
Click image to access complete Table of Contents [...]
Precursors to the PANSS: The BPRS and its progenitors
by Nina R. Schooler, PhD Dr. Schooler is Professor of [...]
A Developmental History of the Positive and Negative Syndrome Scale (PANSS)
by Stacy Liechti, PhD; Gianna Capodilupo, MA; Douglas J. Opler, [...]
Using the Positive and Negative Syndrome Scale (PANSS) to Define Different Domains of Negative Symptoms: Prediction of Everyday Functioning by Impairments in Emotional Expression and Emotional Experience
by Philip D. Harvey, PhD; Anzalee Khan, PhD; and Richard [...]
Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR
by Philip D. Harvey, PhD; Cynthia O. Siu, PhD; and [...]